Terbinafin-Mepha, Crème

7680578650017 CH-57865 Crème
Terbinafin-Mepha, Crème
Terbinafin-Mepha, Crème
Terbinafin-Mepha, Crème
1 / 3
google

Article details

Package size
15
Selling units
15
Measure
g
Galenic form
Crème
Galenic group
Salben

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/09/2025
Patient information leaflet
Français
19/09/2025
Patient information leaflet
Italien
19/09/2025
Summary of Product Characteristics
Allemand
19/09/2025
Summary of Product Characteristics
Français
19/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
10.0 MG Substance HBESI
(N/A)
40.0 MG Substance HBESI
(N/A)
40.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
acidum hydrochloridum 25 per centum
- Substance HNIDK

Reimbursement information

Public price
CHF 9.10
Specialties list
Yes
Generic
Yes
SL addition date: 01/12/2007

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
57865
Drug name
Terbinafin-Mepha, Crème
Galenic form
CREM
ATC Code
D01AE15
Authorization status
Z
Dispensing category
D
First authorization
28/08/2007
Authorization expiration date
31/12/9999
IT Number
10.09.4.
Domain
Human medicine
Field of application
Mittel gegen Hautpilzerkrankungen

Package details

Description (FR)
TERBINAFIN Mepha crème tb 15 g
Description (DE)
TERBINAFIN Mepha Creme Tb 15 g
Market launch
28/08/2007
Narcotic (BTM)
No